Transcatheter aortic valve implantation in severe aortic stenosis does not necessarily reverse left ventricular myocardial damage: data of long-term follow-up

Author:

Myon Frederic1,Marut Benjamin1,Kosmala Wojciech2ORCID,Auffret Vincent1ORCID,Leurent Guillaume1ORCID,L’official Guillaume1,Curtis Elizabeth1,Le Breton Herve1,Oger Emmanuel3ORCID,Donal Erwan1ORCID

Affiliation:

1. Cardiologie, CHU de RENNES, LTSI UMR1099, INSERM, Université de Rennes , Rennes , France

2. Institute of Heart Diseases, Wroclaw Medical University , Poland

3. EA Reperes, CHU Rennes, University of Rennes , Rennes , France

Abstract

Abstract Aims Aortic stenosis (AS) is causing myocardial damage and replacement is mainly indicated based on symptoms. Non-invasive estimation of myocardial work (MW) provides a less afterload-dependent too for assessing myocardial function. We sought to look at the impact of transcatheter aortic valve implantation (TAVI) on the myocardium at long-term follow-up and according to current indications. Methods and results We conducted an observational, cross-sectional, single-centre study. Patients were selected based on the validated indication for a TAVI. Standardized echocardiographies were repeated. A total of 102 patients were included. The mean age was 85 years, 45% were female, 68% had high blood pressure, and 52% had a coronary disease. One-fifth was suffering from low-flow–low-gradient AS. A follow-up was performed at 22 ± 9.5 months after the TAVI. No TAVI dysfunction was observed. Left ventricular (LV) ejection fraction was stable (62 ± 8%), and global longitudinal strain had improved (−14.0 ± 3.7 vs. −16.0 ± 3.6%, P < 0.0001). No improvement of the MW parameters was noticed (LV global work index 2099 ± 692 vs. 2066 ± 706 mmHg%, P = 0.8, LV global constructive 2463 ± 736 vs. 2463 ± 676 mmHg%, P = 0.8). Global wasted work increased [214 (149; 357) vs. 247 (177; 394) mmHg%, P = 0.0008]. Conclusion In a population of severe symptomatic AS patients who had undergone a TAVI, the non-invasive myocardial indices that assess the LV performance at long-term follow-up did not improve. These results are questioning the timing of the intervention and the need for more attention in the pharmacological management of these AS patients.

Publisher

Oxford University Press (OUP)

Reference36 articles.

1. Contemporary presentation and management of valvular heart disease: the EURObservational Research Programme Valvular Heart Disease II survey;Iung;Circulation,2019

2. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Otto;Circulation,2021

3. 2021 ESC/EACTS guidelines for the management of valvular heart disease;Vahanian;Eur Heart J,2022

4. Managing patients with moderate aortic stenosis;Stassen;JACC Cardiovasc Imaging,2023

5. Cardiac damage and quality of life after aortic valve replacement in the PARTNER trials;Généreux;J Am Coll Cardiol,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3